New combo approach targets limited-spread breast cancer: surgery plus radiation may extend life
NCT ID NCT07578116
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study looks at whether adding focused treatments like surgery and radiation to standard drug therapy can help people with HER2-positive stage IV breast cancer that has spread to only a few spots. About 562 participants will either get standard drugs alone or drugs plus local treatments. The goal is to see if the combination helps people live longer or keeps the cancer from growing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.